Optovue will debut its AngioVue® Essential OCTA capability for optometry and general ophthalmology at the More
Optovue will highlight its AngioVue® Essential OCTA capability for general ophthalmology, along with its suite More
Optovue announced today that the FDA has cleared the company's epithelial thickness mapping software More
Optovue is the first company to offer higher density OCTA imaging that provides significant improvement More
Optovue will showcase its suite of advanced eye care technology at the AAO 2016 meeting in Chicago More
Optovue announced the availability of DualTrac™ Motion Correction technology on the AngioVue™ Imaging System More
AngioVue Retina is configured with essential OCTA and OCT features designed specifically for retinal practices More
Optovue announced FDA clearance and immediate U.S. commercial availability of the AngioVue™ Imaging System More
Optovue today announced commercial availability of AngioAnalytics™, the next generation of its OCTA technology More
Find out about all our events and news by subscribing to our monthly newsletter.